Fig. 5 

The effect of engineered T cells targeting ovarian cancer cell line in vivo. A Representative bioluminescence images of tumor killing capacity of engineered T cells in NSD/SCID mice with SKOV3-LucG xenograft model. B Quantification of bioluminescence kinetics of SKOV3-LucG tumor growth in the xenograft model after T cell injection at day 11. C The tumor size of each group was measured via a Vernier caliper. D The Kaplan–Meier survival curve of mice in the SKOV3-LucG xenograft model. Mice were sacrificed when the tumor volume reached 2000 mm³. All data are presented as the mean ± SEM of triplicate experiments. *p < 0.05, **p < 0.01, ***p < 0.001, P > 0.05 labeled as N.S was considered no significance